Back to Results
Daniel Ollendorf, PhD, MPH
Meet Daniel Ollendorf, PhD, MPH
Title(s)
Director of Value Measurement & Global Health Initiatives, Center for the Evaluation of Value and Risk in Health (CEVR); Assistant Professor, Tufts University School of Medicine
Department + Services
Institute for Clinical Research and Health Policy Studies (ICRHPS), Center for the Evaluation of Value and Risk in Health (CEVR)
Research Focus Areas
Appropriate use and application of comparative effectiveness research, cost-effectiveness evaluation, and budget impact analysis in the setting of health technology assessment (HTA)
2018, Alternate Awardee, Fulbright Senior Scholar Award Program
2009, Outstanding Peer Review Recognition Award, Journal of Managed Care and Specialty Pharmacy
2001, Employee Leadership Award, PharMetrics, Inc.
1986, Cum Laude, College of Arts and Sciences, University of Rochester
1986, Departmental Distinction, Department of Medicine/Community Health, University of Rochester
1983-1986, University Honors and Dean’s List, College of Arts and Sciences, University of Rochester
Daniel Ollendorf, PhD is Director of Value Measurement and Global Health Initiatives at CEVR and Assistant Professor of Medicine at Tufts University School of Medicine. Dr. Ollendorf’s research interests include expanding the use of health technology assessment (HTA) and economic evaluation in low- and middle-income countries, as well as refinement and use of value assessment tools in the United States and other high-income settings. Prior to joining CEVR, Dr. Ollendorf was Chief Scientific Officer for the Institute for Clinical and Economic Review (ICER) for over 10 years, where he oversaw the broader HTA process and managed relationships with multiple stakeholders and research collaborators.
Dr. Ollendorf is non-resident Fellow in Global Health at the Center for Global Development, and currently serves as the Chair of the Health Technology Assessment International (HTAi) Global Policy Forum. He received his PhD in Clinical Epidemiology from the University of Amsterdam, and an MPH in Health Policy & Management/Epidemiology from Boston University.
International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Health Technology Assessment International
Organizational Member, Global Policy Forum, Health Technology Assessment International (HTAi)
Scientific Review Group, HTAi
HTA Council Working Group, ISPOR
Global Policy Forum, HTAi
